Joseph Arboleda-Velasquez, MD, PhD, Assistant Professor of Ophthalmology at Harvard Medical School (HMS) and Assistant Scientist at Schepens Eye Research Institute of Mass Eye and Ear, is a 2022 recipient of the Edward N. & Della L. Thome Memorial Foundation Awards Program in Alzheimer's Disease Drug Discovery Research.... Read more about Joseph Arboleda-Velasquez, MD, PhD, Awarded $500,000 in Funding to Support Alzheimer's Research

A key foundation partner to Harvard Ophthalmology, the Massachusetts Lions Eye Research Fund (MLERF) has selected several faculty to receive research awards. For academic year 2021-22, MLERF will provide $420,000 in funding to support innovative research projects across our affiliates.

... Read more about Harvard Ophthalmology Affiliates Receive $420,000 in Lions Grants for Eye Research

Joseph F. Arboleda-Velasquez, MD, PhD, an Assistant Professor of Ophthalmology at Harvard Medical School and assistant scientist at Mass Eye and Ear who studies small vessel disease in the brain and the eye, has been awarded a five-year, $4 million gift from Good Ventures to spur his lab’s groundbreaking work into Alzheimer’s disease genetic resistance.... Read more about Joseph F. Arboleda-Velásquez, MD, PhD, Receives $4 Million Research Gift

Researchers led by a team at Massachusetts Eye and Ear have identified a novel cellular entry factor for adeno-associated virus vector (AAV) types—the most commonly used viral vectors for in vivo gene therapy. AAVs are vectors–or vehicles—that are created from a virus that is made harmless by molecular engineering, and have shown promise transporting genetic therapy treatments to affected tissues.... Read more about Researchers Uncover Mechanism for How Common Gene Therapy Vectors Enter Cells